These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38805616)

  • 1. An Assessment of CAR-T Cell Therapy Utilization among Racial and Ethnic Minority Patients.
    Hill LC; Smith M
    NEJM Evid; 2024 Apr; 3(4):EVIDe2400022. PubMed ID: 38805616
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes.
    Faruqi AJ; Ligon JA; Borgman P; Steinberg SM; Foley T; Little L; Mackall CL; Lee DW; Fry TJ; Shalabi H; Brudno J; Yates B; Mikkilineni L; Kochenderfer J; Shah NN
    Blood Adv; 2022 Dec; 6(23):6040-6050. PubMed ID: 35939781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy.
    Ghassemi S; Milone MC
    J Vis Exp; 2019 Dec; (154):. PubMed ID: 31904011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socioeconomic and Racial Disparity in Chimeric Antigen Receptor T Cell Therapy Access.
    Ahmed N; Shahzad M; Shippey E; Bansal R; Mushtaq MU; Mahmoudjafari Z; Faisal MS; Hoffmann M; Abdallah AO; Divine C; Hamadani M; McGuirk J; Shune L
    Transplant Cell Ther; 2022 Jul; 28(7):358-364. PubMed ID: 35429662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in COVID-19 Mortality in the US by Race and Ethnicity and Educational Attainment.
    Feldman JM; Bassett MT
    JAMA Netw Open; 2021 Nov; 4(11):e2135967. PubMed ID: 34812846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric antigen receptor T-cell therapy for cancer: a basic research-oriented perspective.
    Han C; Kwon BS
    Immunotherapy; 2018 Mar; 10(3):221-234. PubMed ID: 29370727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Organizational Quality and Out-of-Network Primary Care Among Accountable Care Organizations That Care for High vs Low Proportions of Patients of Racial and Ethnic Minority Groups.
    Bakre S; Moloci N; Norton EC; Lewis VA; Si Y; Lin S; Lawton EJ; Herrel LA; Hollingsworth JM
    JAMA Health Forum; 2022 Apr; 3(4):e220575. PubMed ID: 35977323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of CAR structure and culture conditions on memory CAR-T cells.
    Pei WC; Hu J; Song JH; Wang WF; He YY; Pang WJ; Huang Y
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2313-2317. PubMed ID: 33755968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric Antigen Receptor (CAR) T-Cell Therapy.
    Pagel JM; West HJ
    JAMA Oncol; 2017 Nov; 3(11):1595. PubMed ID: 28880983
    [No Abstract]   [Full Text] [Related]  

  • 10. Implications of CAR-T cell therapy on apheresis services: a Scottish perspective.
    Horne GA; Laird J; Latif AL; Irvine D; Wilson M; Douglas K
    J Clin Apher; 2021 Jun; 36(3):513-515. PubMed ID: 33378123
    [No Abstract]   [Full Text] [Related]  

  • 11. Are chimeric antigen receptor T cells (CAR-T cells) the future in immunotherapy for autoimmune diseases?
    Santamaria-Alza Y; Vasquez G
    Inflamm Res; 2021 Jun; 70(6):651-663. PubMed ID: 34018005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities in Sexually Transmitted Infection/HIV Testing, Contraception, and Emergency Contraception Care Among Adolescent Sexual Minority Women Who Are Racial/Ethnic Minorities.
    Makrides J; Matson P; Arrington-Sanders R; Trent M; Marcell AV
    J Adolesc Health; 2023 Feb; 72(2):214-221. PubMed ID: 36369111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the Thematic Nature of Microaggression among Racial and Ethnic Minority Surgeons.
    Appah-Sampong A; Zakrison T; Vela M; Saunders M; Zhang L; Dorsey C
    J Am Coll Surg; 2022 Aug; 235(2):210-216. PubMed ID: 35839395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric Antigen Receptor T Cell Immunotherapy for Tumor: A Review of Patent Literatures.
    Fu M; Tang L
    Recent Pat Anticancer Drug Discov; 2019; 14(1):60-69. PubMed ID: 30636615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Future of Chimeric Antigen Receptor T Cell Therapy for the Treatment of Multiple Myeloma.
    Cornell RF; Costa LJ
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):e73-e75. PubMed ID: 30448457
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolution of chimeric antigen receptor (CAR) T cell therapy: current status and future perspectives.
    Lee YH; Kim CH
    Arch Pharm Res; 2019 Jul; 42(7):607-616. PubMed ID: 30830661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Companion vaccines for CAR T-cell therapy: applying basic immunology to enhance therapeutic efficacy.
    E Snook A
    Future Med Chem; 2020 Aug; 12(15):1359-1362. PubMed ID: 32597219
    [No Abstract]   [Full Text] [Related]  

  • 18. Construction of a chimeric antigen receptor bearing a nanobody against prostate a specific membrane antigen in prostate cancer.
    Hassani M; Hajari Taheri F; Sharifzadeh Z; Arashkia A; Hadjati J; van Weerden WM; Modarressi MH; Abolhassani M
    J Cell Biochem; 2019 Jun; 120(6):10787-10795. PubMed ID: 30672018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials: A Systematic Review.
    Reddy KP; Faggioni M; Eberly LA; Halaby R; Sanghavi M; Lewey J; Mehran R; Coylewright M; Herrmann HC; Giri J; Fanaroff AC; Nathan AS
    JAMA Cardiol; 2023 Sep; 8(9):871-878. PubMed ID: 37494015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of exhaustion in CAR T cell therapy.
    Delgoffe GM; Xu C; Mackall CL; Green MR; Gottschalk S; Speiser DE; Zehn D; Beavis PA
    Cancer Cell; 2021 Jul; 39(7):885-888. PubMed ID: 34256903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.